Politis, M., Crawford, L. , Jani, B. D. , Nicholl, B. I. , Lewsey, J. , McAllister, D. A. , Mair, F. S. and Hanlon, P. (2024) An observational analysis of frailty in combination with loneliness or social isolation and their association with socioeconomic deprivation, hospitalisation and mortality among UK Biobank participants. Scientific Reports, 14, 7258. (doi: 10.1038/s41598-024-57366-7)

Hanlon, P. , Wightman, H., Politis, M., Kirkpatrick, S., Jones, C. , Andrew, M. K., Vetrano, D. L., Dent, E. and Hoogendijk, E. O. (2024) The relationship between frailty and social vulnerability: a systematic review. Lancet Healthy Longevity, 5(3), e214-e226. (doi: 10.1016/S2666-7568(23)00263-5)

Hanlon, P. , Welsh, S. A. and Evans, N. R. (2024) Constructing a quality frailty index: you get out what you put in. Age and Ageing, 53(1), afad248. (doi: 10.1093/ageing/afad248) (PMID:38266125)

Crowther, J. , Butterly, E. W., Hannigan, L. J. , Guthrie, B., Wild, S., Mair, F. S. , Hanlon, P. , Chadwick, F. J. and McAllister, D. (2023) Correlations between comorbidities in trials and the community: an individual-level participant data meta-analysis. Journal of Multimorbidity and Comorbidity, 13, pp. 1-9. (doi: 10.1177/26335565231213571) (PMID:37953975) (PMCID:PMC10637135)

Dent, E. et al. (2023) Recent developments in frailty identification, management, risk factors and prevention: a narrative review of leading journals in geriatrics and gerontology. Ageing Research Reviews, 91, 102082. (doi: 10.1016/j.arr.2023.102082) (PMID:37797723)

Jani, B. D. , Sullivan, M. K. , Hanlon, P. , Nicholl, B. I. , Lees, J. S. , Brown, L., MacDonald, S. , Mark, P. B. , Mair, F. S. and Sullivan, F. M. (2023) Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role? British Journal of Cancer, (doi: 10.1038/s41416-023-02467-9) (PMID:37880510) (Early Online Publication)

Hanlon, P. , Burton, J. K. , Quinn, T. J. , Mair, F. S. , McAllister, D. , Lewsey, J. and Gallacher, K. I. (2023) Prevalence, measurement and implications of frailty in stroke survivors: an analysis of three global aging cohorts. International Journal of Stroke, 18(6), pp. 720-727. (doi: 10.1177/17474930231151847) (PMID:36621981) (PMCID:PMC10311928)

Wightman, H., Quinn, T. J. , Mair, F. S. , Lewsey, J. , McAllister, D. A. and Hanlon, P. (2023) Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition. Alzheimer's Research and Therapy, 15, 110. (doi: 10.1186/s13195-023-01260-3) (PMID:37312157) (PMCID:PMC10262528)

Hanlon, P. et al. (2023) Treatment effect modification due to comorbidity: individual participant data meta-analyses of 120 randomised controlled trials. PLoS Medicine, 20(6), e1004176. (doi: 10.1371/journal.pmed.1004176) (PMID:37279199) (PMCID:PMC10243630)

Hanlon, P. , Guo, X., McGhee, E., Lewsey, J. , McAllister, D. and Mair, F. S. (2023) Systematic review and meta-analysis of prevalence, trajectories, and clinical outcomes for frailty in COPD. npj Primary Care Respiratory Medicine, 33, 1. (doi: 10.1038/s41533-022-00324-5) (PMID:36604427) (PMCID:PMC9816100)

Butterly, E. W. et al. (2023) Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: an individual participant data meta-analysis. PLoS Medicine, 20(1), e1004154. (doi: 10.1371/journal.pmed.1004154) (PMID:36649256) (PMCID:PMC9844862)

Sullivan, M. K. et al. (2022) The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function. BMC Medicine, 20, 420. (doi: 10.1186/s12916-022-02628-2) (PMID:36320059) (PMCID:PMC9623942)

Hanlon, P. , Butterly, E., Shah, A. S. V., Hannigan, L. J. , Wild, S. H., Guthrie, B., Mair, F. S. , Dias, S., Welton, N. J. and McAllister, D. A. (2022) Assessing trial representativeness using Serious Adverse Events: An observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data. BMC Medicine, 20, 410. (doi: 10.1186/s12916-022-02594-9) (PMID:36303169) (PMCID:PMC9615407)

Hanlon, P. , Morrison, H., Morton, F. , Jani, B. D. , Siebert, S. , Lewsey, J. , McAllister, D. and Mair, F. S. (2022) Frailty in people with rheumatoid arthritis: a systematic review of observational studies. Wellcome Open Research, 6, 244. (doi: 10.12688/wellcomeopenres.17208.2)

Hanlon, P. , Lewsey, J. , Quint, J. K., Jani, B. D. , Nicholl, B. I. , McAllister, D. A. and Mair, F. S. (2022) Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank. BMJ Open Respiratory Research, 9, e001314. (doi: 10.1136/bmjresp-2022-001314) (PMID:35787523) (PMCID:PMC9255399)

Hanlon, P. , Jani, B. D. , Nicholl, B. , Lewsey, J. , McAllister, D. A. and Mair, F. S. (2022) Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: a comparison of longitudinal cohort studies. PLoS Medicine, 19(3), e1003931. (doi: 10.1371/journal.pmed.1003931) (PMID:35255092) (PMCID:PMC8901063)

Hanlon, P. , Morton, F. , Siebert, S. , Jani, B. D. , Nicholl, B. I. , Lewsey, J. , McAllister, D. and Mair, F. S. (2022) Frailty in rheumatoid arthritis and its relationship with disease activity, hospitalisation and mortality: a longitudinal analysis of the Scottish Early Rheumatoid Arthritis cohort and UK Biobank. RMD Open, 8(1), e002111. (doi: 10.1136/rmdopen-2021-002111) (PMID:35292529) (PMCID:PMC8928366)

Lees, J. S. et al. (2022) Effect of age, sex, and morbidity count on trial attrition: meta-analysis of individual participant level data from phase 3/4 industry funded clinical trials. BMJ Medicine, 1(1), e000217. (doi: 10.1136/bmjmed-2022-000217) (PMID:36936559) (PMCID:PMC9978693)

Sullivan, M. K. et al. (2021) Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings. BMC Medicine, 19, 278. (doi: 10.1186/s12916-021-02147-6)

Hanlon, P. et al. (2021) Self-management interventions for Type 2 Diabetes: systematic review protocol focusing on patient workload and capacity support. Wellcome Open Research, 6, 257. (doi: 10.12688/wellcomeopenres.17238.1) (PMID:35928807) (PMCID:PMC9308000)

Hanlon, P. , Jani, B. D. , Butterly, E., Nicholl, B. , Lewsey, J. , McAllister, D. A. and Mair, F. S. (2021) An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes. Communications Medicine, 1, 28. (doi: 10.1038/s43856-021-00029-9)

Burton, J. K. et al. (2021) Impact of COVID-19 on care-home mortality and life expectancy in Scotland. Age and Ageing, 50(4), pp. 1029-1037. (doi: 10.1093/ageing/afab080) (PMID:33914870) (PMCID:PMC8135527)

Hanlon, P. , Corcoran, N. , Rughani, G., Shah, A. S.V., Mair, F. S. , Guthrie, B., Renton, J. P. and McAllister, D. A. (2021) Observed and expected serious adverse event rates in randomised clinical trials for hypertension: an observational study comparing trials that do and do not focus on older people. Lancet Healthy Longevity, 2(7), e398-e406. (doi: 10.1016/S2666-7568(21)00092-1) (PMID:34240062) (PMCID:PMC8245327)

Rughani, G., Hanlon, P. , Corcoran, N. and Mair, F. (2021) The readability of general practice websites: a cross-sectional analysis of all general practice websites in Scotland. British Journal of General Practice, 71(706), e391-e398. (doi: 10.3399/BJGP.2020.0820) (PMID:33824159) (PMCID:PMC8049218)

Hanlon, P. et al. (2021) COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study. Wellcome Open Research, 5, 75. (doi: 10.12688/wellcomeopenres.15849.3) (PMID:33709037) (PMCID:PMC7927210)

Jani, B. D. , McQueenie, R., Nicholl, B. I. , Field, R. , Hanlon, P. , Gallacher, K. I. , Mair, F. S. and Lewsey, J. (2021) Association between patterns of alcohol consumption (beverage type, frequency and consumption with food) and risk of adverse health outcomes: a prospective cohort study. BMC Medicine, 19, 8. (doi: 10.1186/s12916-020-01878-2) (PMID:33430840) (PMCID:PMC7802201)

Hanlon, P. , Faure, I., Corcoran, N. , Butterly, E., Lewsey, J. , McAllister, D. and Mair, F. S. (2020) Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis. Lancet Healthy Longevity, 1(3), e106-e116. (doi: 10.1016/S2666-7568(20)30014-3) (PMID:33313578) (PMCID:PMC7721684)

Petermann-Rocha, F. et al. (2020) Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank. BMC Medicine, 18, 355. (doi: 10.1186/s12916-020-01822-4) (PMID:33167965) (PMCID:PMC7652674)

Hanlon, P. , Butterly, E., Lewsey, J. , Siebert, S. , Mair, F. S. and McAllister, D. A. (2020) Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions. BMC Medicine, 18, 309. (doi: 10.1186/s12916-020-01752-1) (PMID:33087107) (PMCID:PMC7579922)

Hanlon, P. , Fauré, I., Corcoran, N. , Butterly, E., Lewsey, J. , McAllister, D. A. and Mair, F. S. (2020) The identification and prevalence of frailty in diabetes mellitus and association with clinical outcomes: a systematic review protocol. BMJ Open, 10(9), e037476. (doi: 10.1136/bmjopen-2020-037476) (PMID:32873673) (PMCID:PMC7467518)

Hanlon, P. , McCallum, M. , Jani, B. D. , McQueenie, R., Lee, D. and Mair, F. S. (2020) Association between childhood maltreatment and the prevalence and complexity of multimorbidity: a cross-sectional analysis of 157,357 UK Biobank participants. Journal of Comorbidity, 10, pp. 1-12. (doi: 10.1177/2235042X10944344)

Hanlon, P. , Hannigan, L. , Rodriguez-Perez, J., Fischbacher, C., Welton, N. J., Dias, S., Mair, F. S. , Guthrie, B., Wild, S. and McAllister, D. (2019) Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis. BMC Medicine, 17, 201. (doi: 10.1186/s12916-019-1427-1) (PMID:31711480) (PMCID:PMC6849229)